Pyrazole-Thiazole Core-Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem-Resistant Enterobacteriaceae (CRE)

被引:3
|
作者
Kim, Chungsik [1 ]
Kassu, Mintesinot [1 ]
Smith, Kenneth P. [3 ]
Kirby, James E. [3 ]
Manetsch, Roman [1 ,2 ]
机构
[1] Northeastern Univ, Dept Chem & Chem Biol, 360 Huntington Ave, Boston, MA 02115 USA
[2] Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
antibacterial activity; carbapenem-resistant enterobacteriaceae; adjunctive activity; meropenem; GRAM-NEGATIVE BACTERIA; BLOOD-STREAM; INFECTIONS; DESIGN; COMBINATION; DERIVATIVES; INHIBITORS;
D O I
10.1002/cmdc.202100321
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrazole-thiazole core-containing compound KP-40 and 20 novel derivatives were designed and synthesized through traditional SAR analysis. These molecules displayed adjunctive activity with meropenem against Gram-negative bacteria evidenced by a range of fractional inhibitory concentration (FIC=0.5-0.25) and minimum adjunctive concentration (MAC=128-32 mu M) values. Of this series of molecules, four compounds displayed notable adjunctive potential, with FIC and MAC values of 0.25 and 32 mu M, respectively. Moreover, the solubility of these compounds was improved to an acceptable range. Further analysis using our "in house" permeation and efflux multi parameter optimization (PEMPO) algorithm revealed key physicochemical properties that may be critical for the development of active Gram-negative antibacterials. Taking PEMPO scores into consideration prior to executing synthesis of analogs may be a simple, yet rapid and effective strategy that can be used in conjunction with traditional SAR approaches to aid in the design of potent Gram-negative antibacterials.
引用
收藏
页码:2775 / 2780
页数:6
相关论文
共 50 条
  • [41] Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe
    Shortridge, Dee
    Deshpande, Lalitagauri M.
    Streit, Jennifer M.
    Castanheira, Mariana
    JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (05):
  • [42] Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in US Hospitals during 2016 to 2018
    Castanheira, Mariana
    Doyle, Timothy B.
    Kantro, Valerie
    Mendes, Rodrigo E.
    Shortridge, Dee
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (02)
  • [43] Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections
    Dubey, Vineet
    Devnath, Kuldip
    Gupta, Vivek K.
    Kalyan, Gazal
    Singh, Mangal
    Kothari, Ashish
    Omar, Balram Ji
    Pathania, Ranjana
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (05) : 1313 - 1323
  • [44] Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens
    Biagi, M.
    Shajee, A.
    Vialichka, A.
    Jurkovic, M.
    Tan, X.
    Wenzler, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [45] Discovery of Broad-Spectrum Repurposed Drug Combinations Against Carbapenem-Resistant Enterobacteriaceae (CRE) Through Artificial Intelligence (AI)-Driven Platform
    Li, Ming
    You, Kui
    Wang, Peter
    Hooi, Lissa
    Chen, Yahua
    Siah, Anqi
    Tan, Shi-Bei
    Teo, Jeanette
    Ng, Oon-Tek
    Marimuthu, Kalisvar
    Venkatachalam, Indumathi
    Blasiak, Agata
    Chow, Edward Kai-Hua
    Ho, Dean
    Gan, Yunn-Hwen
    ADVANCED THERAPEUTICS, 2024, 7 (03)
  • [46] Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology
    Brennan-Krohn, Thea
    Truelson, Katherine A.
    Smith, Kenneth P.
    Kirby, James E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (10) : 2775 - 2781
  • [47] Dual-Function Potentiation by PEG-BPEI Restores Activity of Carbapenems and Penicillins against Carbapenem-Resistant Enterobacteriaceae
    Panlilio, Hannah
    Lam, Anh K.
    Heydarian, Neda
    Haight, Tristan
    Wouters, Cassandra L.
    Moen, Erika L.
    Rice, Charles, V
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1657 - 1665
  • [48] Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae
    Haidar, Ghady
    Clancy, Cornelius J.
    Chen, Liang
    Samanta, Palash
    Shields, Ryan K.
    Kreiswirth, Barry N.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
  • [49] Identification of LYS228: A Novel monobactam with activity against extended spectrum β-lactamase expressing and carbapenem-resistant enterobacteriaceae
    Casarez, Anthony
    Bermingham, Alun
    Blais, Johanne
    Capka, Vladimir
    Colvin, Richard
    Dean, Charles
    Fekete, Alexander
    Gong, Wanben
    Growcott, Ellena
    Guo, Hongqui
    Lin, Xiaodong
    Lindvall, Mika
    Lopez, Sara
    McKenney, David
    Moser, Heinz
    Rasper, Dita
    Sethuraman, Vijay
    Shen, Xiaoyu
    Simmons, Robert
    Tang, Dazhi
    Tjandra, Meiliana
    Turner, Nancy
    Uehara, Tsuyoshi
    Vitt, Charles
    Whitebread, Steven
    Yifru, Aregahegn
    Zang, Xu
    Zhu, Qingming
    Reck, Folkert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [50] In-vitro activity of plazomicin, meropenem-vaborbactam, and omadacycline against carbapenem-resistant Gram-negative isolates in Egypt
    Gadallah, Mona Abd El-Aziz
    El-sayed, Wasila Moursy
    Hussien, Mohammed Zakaria
    Elheniedy, Mohammed Ahmed
    Maxwell, Sara Youssef
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (03) : 205 - 218